116 related articles for article (PubMed ID: 30215539)
1. Effect of diammonium glycyrrhizinate on pharmacokinetics of omeprazole by regulating cytochrome P450 enzymes and plasma protein binding rate.
Han L; Wang R; Wu B; Gu Y; Yuan Y
Xenobiotica; 2019 Aug; 49(8):975-980. PubMed ID: 30215539
[TBL] [Abstract][Full Text] [Related]
2. Effects of diammonium glycyrrhizinate on the pharmacokinetics of aconitine in rats and the potential mechanism.
Chen L; Yang J; Davey AK; Chen YX; Wang JP; Liu XQ
Xenobiotica; 2009 Dec; 39(12):955-63. PubMed ID: 19831503
[TBL] [Abstract][Full Text] [Related]
3. Effect of diammonium glycyrrhizinate on entecavir pharmacokinetics in rats.
Li FY; Hao HP; Hao K; Yan TT; Wang GJ
Chin J Nat Med; 2013 May; 11(3):309-13. PubMed ID: 23725847
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis.
Yuan H; Ji WS; Wu KX; Jiao JX; Sun LH; Feng YT
World J Gastroenterol; 2006 Jul; 12(28):4578-81. PubMed ID: 16874877
[TBL] [Abstract][Full Text] [Related]
5. [Diammonium glycyrrhizinate does not affect efficacy of adefovir dipivoxil therapy in patients with HBeAg-positive chronic hepatitis B].
Li J; Zhao H; Si CW; Zhang YX; Chen XY; Wang L; Tang XP; Lei CL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):270-2. PubMed ID: 17971943
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous and comprehensive in vivo analysis of cytochrome P450 activity by using a cocktail approach in rats.
Uchida S; Tanaka S; Namiki N
Biopharm Drug Dispos; 2014 May; 35(4):228-36. PubMed ID: 24395703
[TBL] [Abstract][Full Text] [Related]
7. Effects of diammonium glycyrrhizinate on hepatic and intestinal UDP-Glucuronosyltransferases in rats: Implication in herb-drug interactions.
Li FY; Xie H; Weng L; Wang H; Cao LJ; Hao HP; Wang GJ
Chin J Nat Med; 2016 Jul; 14(7):534-40. PubMed ID: 27507204
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.
Zhang W; Han F; Guo P; Zhao H; Lin ZJ; Huang MQ; Bertelsen K; Weng N
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1169-77. PubMed ID: 20378422
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of magnesium glycyrrhizinate following intravenous administration of magnesium glycyrrhizinate in rats.
Hu Q; Ding J; Liu S; Li P; Hu G
Eur J Drug Metab Pharmacokinet; 2003; 28(4):259-64. PubMed ID: 14743966
[TBL] [Abstract][Full Text] [Related]
10. Effect of Evodiamine on CYP Enzymes in Rats by a Cocktail Method.
Zhang YT; Zhang DF; Ge NY; Zhu GH; Hao C; Zhang Y; Chen RJ
Pharmacology; 2016; 97(5-6):218-23. PubMed ID: 26872133
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of bupropion, metroprolol, midazolam, phenacetin, omeprazole and tolbutamide in rat plasma by UPLC-MS/MS and its application to cytochrome P450 activity study in rats.
Ma J; Wang S; Zhang M; Zhang Q; Zhou Y; Lin C; Lin G; Wang X
Biomed Chromatogr; 2015 Aug; 29(8):1203-12. PubMed ID: 25582505
[TBL] [Abstract][Full Text] [Related]
12. [A meta-analysis of diammonium glycyrrhizinate enteric-coated capsules versus diammonium glycyrrihizinate in patients with chronic viral hepatitis].
Ling Q; Jin H; Zheng J; Shi G
Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):411-5. PubMed ID: 25203702
[TBL] [Abstract][Full Text] [Related]
13. Effects of suberoylanilide hydroxamic acid on rat cytochrome P450 enzyme activities.
Lin K; Zhang Q; Liu Z; Yang S; Lin Y; Wen C; Zheng Y
Int J Clin Exp Pathol; 2015; 8(5):5584-90. PubMed ID: 26191268
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the impact of Polygonum capitatum, a traditional Chinese herbal medicine, on rat hepatic cytochrome P450 enzymes by using a cocktail of probe drugs.
Zheng L; Lu Y; Cao X; Huang Y; Liu Y; Tang L; Liao SG; Wang AM; Li YJ; Lan YY; Wang YL
J Ethnopharmacol; 2014 Dec; 158 Pt A():276-82. PubMed ID: 25446640
[TBL] [Abstract][Full Text] [Related]
15. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
[TBL] [Abstract][Full Text] [Related]
16. A UHPLC-MS/MS method coupled with liquid-liquid extraction for the quantitation of phenacetin, omeprazole, metoprolol, midazolam and their metabolites in rat plasma and its application to the study of four CYP450 activities.
Wang Z; Sun W; Lin ZF; Sun R; Huang CK; Ye WJ; Dong YY; Zhang XD; Chen RJ
J Pharm Biomed Anal; 2019 Jan; 163():204-210. PubMed ID: 30317077
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19.
Bertilsson L; Tybring G; Widén J; Chang M; Tomson T
Br J Clin Pharmacol; 1997 Aug; 44(2):186-9. PubMed ID: 9278208
[TBL] [Abstract][Full Text] [Related]
18. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
[TBL] [Abstract][Full Text] [Related]
19. Effect of Cimetidine and Phenobarbital on metabolite kinetics of Omeprazole in rats.
Park EJ; Cho HY; Lee YB
Arch Pharm Res; 2005 Oct; 28(10):1196-202. PubMed ID: 16276979
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic of four probe drugs in adriamycin-induced nephropathy rat.
Chen ZB; Zhi AY; Lin FY; Li D; Yu XG; Chen WH; Hu LF
Eur Rev Med Pharmacol Sci; 2014; 18(10):1439-47. PubMed ID: 24899600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]